Free Trial
LON:IXI

IXICO (IXI) Share Price, News & Analysis

IXICO logo
GBX 7.88 -0.37 (-4.48%)
As of 08:22 AM Eastern

About IXICO Stock (LON:IXI)

Key Stats

Today's Range
7.50
8.25
50-Day Range
8
12.50
52-Week Range
6.45
13
Volume
41,875 shs
Average Volume
31,747 shs
Market Capitalization
£7.30 million
P/E Ratio
N/A
Dividend Yield
1.27%
Price Target
N/A
Consensus Rating
N/A

Company Overview

IXICO is a fast growing and profitable medical data analytics company, providing data management and advanced analytics to the pharmaceutical clinical trials market. Established in 2004 and listed as a public company in October 2013, IXICO has firmly established itself as a trusted partner to the global pharmaceutical industry developing new therapies for neurological conditions such as Alzheimer’s, Parkinson’s and Huntington’s disease. Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience. We will focus on developing and deploying breakthrough data analytics, at scale, through our remote access technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for our pharmaceutical clients. Our integrated technology offering encompasses every stage of clinical drug development through to post marketing surveillance and we continue to invest in infrastructure and innovation to support our ambitious growth strategy. Our competitive advantage is our dedication to address complex unmet clinical research needs by partnering and collaborating with clients and academic partners early in the drug development cycle to identify and validate promising new imaging and digital biomarkers.

Remove Ads
Receive IXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IXICO and its competitors with MarketBeat's FREE daily newsletter.

IXI Stock News Headlines

Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
IXICO Partners with PETNET Solutions to Enhance Neuroimaging Services
IXICO Full Year 2024 Earnings: Beats Expectations
See More Headlines

IXI Stock Analysis - Frequently Asked Questions

IXICO's stock was trading at GBX 12.50 at the start of the year. Since then, IXI shares have decreased by 37.0% and is now trading at GBX 7.88.
View the best growth stocks for 2025 here
.

IXICO plc (LON:IXI) posted its earnings results on Wednesday, December, 4th. The company reported ($4.14) earnings per share for the quarter. IXICO had a negative net margin of 31.10% and a negative trailing twelve-month return on equity of 19.14%.

Shares of IXI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that IXICO investors own include BioNTech (BNTX), Benefitfocus (BNFT), Grayscale Bitcoin Trust (GBTC), Motif Bio (MTFB), Pfizer (PFE), Tesla (TSLA) and VEON (VEON).

Company Calendar

Last Earnings
12/04/2024
Today
4/01/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:IXI
CIK
N/A
Fax
N/A
Employees
89
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.38
Net Income
£-3,576,241.73
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£11.50 million
Cash Flow
GBX 3.51 per share
Price / Cash Flow
2.25
Book Value
GBX 19.57 per share
Price / Book
0.40

Miscellaneous

Free Float
N/A
Market Cap
£7.32 million
Optionable
Not Optionable
Beta
0.86
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (LON:IXI) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners